...
首页> 外文期刊>Journal of proteome research >Increased Post-Translational Lysine Acetylation of Myelin Basic Protein Is Associated with Peak Neurological Disability in a Mouse Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis
【24h】

Increased Post-Translational Lysine Acetylation of Myelin Basic Protein Is Associated with Peak Neurological Disability in a Mouse Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis

机译:增加髓鞘后髓鞘的后翻晶丙基丙基丙基丙基丙基丙基丙基菌与多发性硬化症的小鼠实验性自身免疫脑髓炎模型中的峰神经性残疾相关

获取原文
获取原文并翻译 | 示例
           

摘要

Citrullination of arginine residues is a post-translational modification (PTM) found on myelin basic protein (MBP), which neutralizes MBPs positive charge, and is implicated in myelin damage and multiple sclerosis (MS). Here we identify lysine acetylation as another neutralizing PTM to MBP that may be involved in myelin damage. We quantify changes in lysine and arginine PTMs on MBP derived from mice induced with an experimental autoimmune encephalomyelitis (EAE) model of MS using liquid chromatography tandem mass spectrometry. The changes in PTMs are correlated to changes in neurological disability scoring (NDS), as a marker of myelin damage. We found that lysine acetylation increased by 2-fold on MBP during peak NDS post-EAE induction. We also found that mono- and dimethyl-lysine, as well as asymmetric dimethyl-arginine residues on MBP were elevated at peak EAE disability. These findings suggest that the acetylation and methylation of lysine on MBP are PTMs associated with the neurological disability produced by EAE. Since histone deacetylase (HDAC) inhibitors have been previously shown to improve neurological disability, we also show that treatment with trichostatin A (a HDAC inhibitor) improves the NDS of EAE mice but does not change MBP acetylation.
机译:精氨酸残基的瓜氨酸是在髓鞘碱性蛋白(MBP)上发现的翻译后修饰(PTM),其中和Mbps阳性电荷,并涉及髓鞘损伤和多发性硬化症(MS)。在这里,我们将赖氨酸乙酰化作为另一种中和可参与髓鞘损伤的MBP。使用液相色谱串联质谱法量化MS诱导的小鼠衍生的小鼠MBP的MBP和精氨酸PTMS的变化。 PTMS的变化与神经病毒残疾评分(NDS)的变化相关,作为髓鞘损伤的标志物。在EAE诱导期间,我们发现赖氨酸乙酰化在MBP期间增加了2倍。我们还发现单甲基赖氨酸以及MBP上的不对称二甲基精氨酸残基以峰值耐残疾升高。这些发现表明,MBP上赖氨酸的乙酰化和甲基化是与EAE产生的神经功能残疾相关的PTM。由于先前已经显示了组蛋白脱乙酰化酶(HDAC)抑制剂以改善神经障碍,因此我们还表明用richostaTa(HDAC抑制剂)的治疗改善了EAE小鼠的NDS,但不改变MBP乙酰化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号